Kaleigh Fetcko-Fayad is a Neuro Oncology Fellow at Duke University Medical Center, graduating in June 2024. She completed neurology residency training at the University of Illinois at Chicago and medical school at Indiana University School of Medicine. Her research interests include immunotherapy for high-grade gliomas, radiomics of primary brain tumors, and steroid-sparing alternative treatments for peritumoral brain edema. She is board-certified in adult neurology by the American Board of Psychiatry and Neurology. She is a member of the American Academy of Neurology and the Society of Neuro Oncology.
Kaleigh Fetcko-Fayad is a Neuro Oncology Fellow at Duke University Medical Center, graduating in June 2024. She completed neurology residency training at the University of Illinois at Chicago and medical school at Indiana University School of Medicine. Her research interests include immunotherapy for high-grade gliomas, radiomics of primary brain tumors, and steroid-sparing alternative treatments for peritumoral brain edema. She is board-certified in adult neurology by the American Board of Psychiatry and Neurology. She is a member of the American Academy of Neurology and the Society of Neuro Oncology.